Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
about
Urinary neopterin levels in patients with thyroid cancerSerum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method.Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancerCytokines and their receptors as biomarkers of systemic lupus erythematosus.Promising biomarkers for systemic lupus erythematosus.Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.Early and exudative age-related macular degeneration is associated with increased plasma levels of soluble TNF receptor II.Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.Association Between TNF-α Promoter -308 A/G Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Case-Control Study and Meta-Analysis.Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
P2860
Q33808410-5B89C149-7968-4DBE-BB24-59E065B97338Q35631856-C947DB11-8FD0-4D1E-8456-66FCC251780AQ36433143-0FB2A7ED-6883-48FB-BBE0-0B903DA9A08CQ36813475-A9FBBE69-7DF1-4BB2-B801-1BC6B9A714ECQ37118987-1C652039-0064-42F5-BBAF-E9784AA70B5AQ38149960-A37877B3-6733-4072-BEB9-646AF963D962Q38725746-DED5F439-7A85-4E2F-BD63-38942E889B4AQ39101016-3CC3B425-6CF2-4418-A93C-EFC74B74D7F0Q39418163-BC5CF47F-6131-406B-944D-D2C5681E90E3Q41945144-4493511A-4408-4F80-A69B-359D55C1FD37Q42134678-E26D7F78-1FF6-4500-9E79-9233FFCC9232Q43877853-4FA6371D-13CD-460F-BE64-9F745F0D3936Q50881443-495071C2-AA2E-4F2F-A767-8FD6737E27A0Q51272734-16916F4A-9E88-4976-8301-32C1AAA3417CQ54118549-4356BA19-0840-40FF-9C7D-92F21AFC2D7F
P2860
Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@en
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@nl
type
label
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@en
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@nl
prefLabel
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@en
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@nl
P2093
P1476
Serum neopterin, tumor necrosi ...... systemic lupus erythematosus.
@en
P2093
Hala I El-Gendi
Hanan H Ahmed
Randa A K Mahmoud
P304
P356
10.1016/J.CLINBIOCHEM.2004.11.002
P577
2005-02-01T00:00:00Z